cases we report had blood lead values below 80 ,±g/ 100 ml yet both cases were unequivocally suffering from lead poisoning. In addition, both cases had normal haemoglobin concentrations and so would have escaped detection by screening programmes based on the usual haemoglobin or blood lead criteria. Similar cases have been reported (Waldron, 1971; Gibson et al., 1968) and the latter authors recommended that lead concentrations greater than 60 ,ug/100 ml should prompt further investigation.
Lead in the blood reflects absorption of the metal. Individuals vary in their susceptibility to intoxication and in practice, indices of absorption do not correlate closely with indices of intoxication (Gibson et al., 1968) . It, therefore, seems logical to prefer evidence of intoxication to estimates of absorption both for occupational screening and for confirmation of clinical diagnoses. Of the investigations tabulated for these patients, the measurement of erythrocyte protoporphyrin is too difficult and that of 8-amino laevulinic acid dehydrogenase activity too sensitive (Hernberg and Nikkanen, 1970) (Gibson et al., 1968; HaegerAronsen, 1971 COMA is a common presentation of the known epileptic patient to the acute medical unit. The following two cases are reported to emphasize the importance of excluding deliberate drug overdose in the young epileptic patient whose presenting coma is in any way atypical or prolonged.
Case 1
A 12-year-old girl with a 2-year history of Grand Mal epilepsy was admitted to the Neurology Unit at midnight on 6 December 1972, after being seen at home by her general practitioner. That evening she 
Comments
The usual causes for the known epileptic patient to be admitted to hospital in coma are status epilepticus, prolonged post-ictal unconsciousness and head injury occurring at the time of a convulsion.
It is well recognized that epileptic patients may attempt suicide (Kessel, 1965) since they often have associated psychiatric disturbance (Scott, 1968) , but in both of the above patients the possibilities of psychiatric instability and of deliberate drug overdose were discounted by the parents at the time of admission.
In Case 1, the presenting history and physical findings indicated an acute neurological cause for the coma. Fortunately, a serum barbiturate level was requested and this revealed the true nature of the problem. This patient ingested an overdose of Phenytoin as well as Phenobarbitone, and ataxia, vertigo and dysarthria (her presenting features) are recognized acute toxicity effects of both of these drugs (Graham, 1962) .
In Case 2, the history and examination at the time of admission were consistent with post-ictal coma, but the period of unconsciousness following the suspected single convulsion (usually no longer than an hour, Elliott, 1964) was prolonged and latedeveloping signs once again suggested a neurological cause. In this case, although a later estimation confirmed the overdose, the initial serum barbiturate level (2-4 mg°o 12 hr after ingestion) was within the limits normally accepted for epileptic patients taking regular Phenobarbitone therapy. Serum levels of between 1-5 and 3 5 mg%0 are normally accepted, but levels of up to 6 mg%0 have been recorded (Lous, 1954) .
Undoubtedly, acute barbiturate toxicity is associated with the development of neurological signs, such as depressed tendon reflexes and extensor plantar responses (Carroll, 1969) but it is of interest that both patients showed these changes without gross respiratory or cardiovascular depression.
Following recovery from coma, both patients admitted taking an overdose of drugs and both were found to be psychiatrically disturbed, much to the surprise and chagrin of their parents who, at the time of admission, had unwittingly misled the attendant medical staff.
Acute barbiturate poisoning should therefore be considered in any epileptic patient presenting with atypical coma, even when there is no evidence of possible overdose or of psychiatric instability.
Introduction
Ergotamine poisoning in the human classically manifests as arterial spasm and arterial thrombosis, sometimes leading to gangrene of the extremities. We wish to report a rare vascular complication of ergotamine treatment, venous leg thrombosis which appeared in a woman following an intragluteal injection of ergotamine tartrate given for menorrhagia.
Case report
The patient, a female teacher, aged 38 years, mother of two healthy children, was admitted with the complaint of pain in her left calf. Four days earlier she had severe migraine and took 5 g of aspirin instead of the ergotamine tartrate tablets she was wont to use but which were out of stock. The next morning, on the expected day, her menstruation started, this time, however, with excessive blood loss to an extent she had never experienced before. The severe menorrhagia continued for 3 days until at 10.30 a.m. on the day of admission she received an intragluteal injection of 0.5 mg ergotamine tartrate. Three quarters of an hour later she felt a cramp in the neck muscles and a sensation of severe burning pain radiating along both thighs downward. On lying down the burning pain disappeared but when she tried to rise at 13.00 p.m. she felt a sharp pain in the left calf preventing her from standing. Since the pain continued unabated she was admitted at 18.30 p.m. Noteworthy in her history are frequent attacks of severe migraine of many years duration for which she had been taking various analgesics,
